Gene: FAM237B
Official Full Name: family with sequence similarity 237 member Bprovided by HGNC
Gene Summary: Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17719 | FAM237B Knockout cell line (HeLa) | Human | FAM237B | 1:3~1:6 | Negative | Online Inquiry |
KO17720 | FAM237B Knockout cell line (HCT 116) | Human | FAM237B | 1:2~1:4 | Negative | Online Inquiry |
KO17721 | FAM237B Knockout cell line (A549) | Human | FAM237B | 1:3~1:4 | Negative | Online Inquiry |
FAM237B Gene Knockout Cell Lines are engineered cellular tools developed to specifically silence the FAM237B gene, which has been implicated in various cellular processes such as apoptosis, cell proliferation, and differentiation. These cell lines utilize CRISPR-Cas9 technology for precise gene editing, providing a robust platform for studying the functional role of FAM237B within a controlled environment. By effectively knocking out this gene, researchers can elucidate its contributions to pathological conditions, including cancer and developmental disorders.
The mechanisms by which these knockout cell lines operate are grounded in the CRISPR-Cas9 pathway, which employs a guide RNA to direct the Cas9 endonuclease to the target gene, resulting in double-strand breaks and subsequent loss of gene function. This allows for the examination of gene function through various assays, including proliferation studies, gene expression profiling, and phenotypic analyses. The availability of FAM237B Knockout Cell Lines streamlines research efforts and enhances the potential for high-throughput screening applications.
Scientifically, the importance of these cell lines extends to their use in both fundamental research and potential therapeutic development. By providing deeper insights into the biological role of FAM237B, scientists can make significant strides in understanding its involvement in disease mechanisms, thereby paving the way for novel interventions. Compared to traditional methods such as RNA interference or chemical inhibitors, CRISPR-based knockout provides a more durable and specific method of gene silencing without off-target effects, making it a superior alternative.
For researchers and clinicians alike, FAM237B Gene Knockout Cell Lines present an unparalleled opportunity to investigate gene function with high precision, facilitating breakthroughs in the quest for understanding and treating various diseases. Our company specializes in producing high-quality, meticulously validated biological products, ensuring reliability and reproducibility in your research endeavors. With FAM237B Gene Knockout Cell Lines, you gain access to a cutting-edge resource tailored to enhance your scientific pursuits.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.